The human nasal microbiota and Staphylococcus aureus carriage

Daniel N Frank, Leah M Feazel, Mary T Bessesen, Connie S Price, Edward N Janoff, Norman R Pace, Daniel N Frank, Leah M Feazel, Mary T Bessesen, Connie S Price, Edward N Janoff, Norman R Pace

Abstract

Background: Colonization of humans with Staphylococcus aureus is a critical prerequisite of subsequent clinical infection of the skin, blood, lung, heart and other deep tissues. S. aureus persistently or intermittently colonizes the nares of approximately 50% of healthy adults, whereas approximately 50% of the general population is rarely or never colonized by this pathogen. Because microbial consortia within the nasal cavity may be an important determinant of S. aureus colonization we determined the composition and dynamics of the nasal microbiota and correlated specific microorganisms with S. aureus colonization.

Methodology/principal findings: Nasal specimens were collected longitudinally from five healthy adults and a cross-section of hospitalized patients (26 S. aureus carriers and 16 non-carriers). Culture-independent analysis of 16S rRNA sequences revealed that the nasal microbiota of healthy subjects consists primarily of members of the phylum Actinobacteria (e.g., Propionibacterium spp. and Corynebacterium spp.), with proportionally less representation of other phyla, including Firmicutes (e.g., Staphylococcus spp.) and Proteobacteria (e.g. Enterobacter spp). In contrast, inpatient nasal microbiotas were enriched in S. aureus or Staphylococcus epidermidis and diminished in several actinobacterial groups, most notably Propionibacterium acnes. Moreover, within the inpatient population S. aureus colonization was negatively correlated with the abundances of several microbial groups, including S. epidermidis (p = 0.004).

Conclusions/significance: The nares environment is colonized by a temporally stable microbiota that is distinct from other regions of the integument. Negative association between S. aureus, S. epidermidis, and other groups suggests microbial competition during colonization of the nares, a finding that could be exploited to limit S. aureus colonization.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1. Relative abundance of predominant bacterial…
Figure 1. Relative abundance of predominant bacterial taxa followed longitudinally in healthy adults.
Shading indicates the proportion of each rDNA library represented by a particular rDNA sequence type. Rows represent species or genus-level taxonomic groups and columns represent individual specimens. Data are presented only for the 25 most abundant taxa, which account for 90% of rDNA sequences analyzed.
Figure 2. Similarities between microbiotas determined longitudinally…
Figure 2. Similarities between microbiotas determined longitudinally for healthy adults.
Morisita-Horn Community Similarity Indices (CMH) were calculated for each pairwise combination of samples and plotted as a heatmap that compares all values. Color gradient denotes CMH values, which range from 0.0 (no similarity between communities) to 1.0 (identical communities). Ax: Axilla samples. Grn: Groin samples. Nar: Nares samples.
Figure 3. Comparison of community similarity (C…
Figure 3. Comparison of community similarity (CMH) between specimen types.
The similarity of microbiota in all pairwise combinations of specimens obtained from healthy adults was assessed using the abundance-based Morisita-Horn similarity index (CMH). Boxplots indicate the spread of CMH values calculated for the indicated comparison. Each chart summarizes data for a study participant. For instance, the first boxplot (“A Nar vs. A Nar”) summarizes data for CMH scores for pairs of Subject A nares samples over time. Statistical significances are reported in Table 2.
Figure 4. Similarity of microbiotas determined longitudinally…
Figure 4. Similarity of microbiotas determined longitudinally for healthy adults.
Panel A. Principal Components Analysis of Microbiotas. Colors indicate the subject and anatomical location from which longitudinal specimens were obtained. No sampling time-dependent trends were observed in the data, so datapoints are not labeled with respect to time of collection. Panel B. Hierarchical Clustering. Colors indicate the subject and anatomical location from which longitudinal specimens were obtained. Leafs are labeled by subject and day of collection. See Materials and Methods for details.
Figure 5. Temporal variation in nares microbiotas…
Figure 5. Temporal variation in nares microbiotas of healthy individuals.
Each line plots the similarity of a baseline nares specimen to subsequently collected nares specimens from the same individual. Similarity is based on the Morisita-Horn community similarity index.
Figure 6. Inter-subject variability in nares microbiota.
Figure 6. Inter-subject variability in nares microbiota.
Panel A. Comparison of S. aureus and S. epidermidis proportions in rDNA libraries. Column heights represent relative abundances of particular microbial groups in hospitalized patients and healthy adults. Hospitalized patients are labeled “D” or “V”, based on the hospital ICU at which they were admitted. The dashed lines denote the mean abundances of S. aureus and S. epidermidis -- 4.8% and 9.3% respectively -- in all nares specimens from healthy adults. rDNA sequences were determined by pyrosequencing. Panel B. All other bacteria, grouped at taxonomic-order level. Dashed line represents the mean abundance of Actinomycetales in all nares specimens from healthy adults.
Figure 7. Impact of S. aureus sequences…
Figure 7. Impact of S. aureus sequences on distributions of other nares bacteria.
Panel A. Percent abundance of top twelve genera. Panel B. Percent abundance of top twelve genera adjusted by removal of S. aureus from total sequence counts.
Figure 8. Ecological richness and diversity of…
Figure 8. Ecological richness and diversity of nares microbiotas.
The top panel presents the distributions of species richness indices (Sobs) calculated for nares specimens obtained from hospitalized or healthy adults. The middle panel summarizes sample biodiversity (Shannon diversity index Ho) and the lower panel presents species evenness (Ho/Hmax. Ho = Shannon index; Hmax = maximum value of Ho for a specimen). Significance levels are indicated by * p<0.05; *** p<0.001.
Figure 9. Accuracy of rDNA sequence-based classification…
Figure 9. Accuracy of rDNA sequence-based classification of S. aureus and S. epidermidis.
Each nares sequence classified as S. aureus or S. epidermidis by BLAST query of a highly-curated database (SILVA LTP_S95) was aligned and its pairwise sequence similarity determined in relation to each sequence in a dataset consisting of all LTP_S95 staphylococcal sequences along with other staphylococcal genomic sequences. Maximum percent identity scores were identified both to the predicted species (S. aureus or S. epidermidis) and to all other staphylococci in the dataset. These two scores were plotted for each nares sequence. Points falling above the diagonal line therefore represent nares sequences that were most closely related to the species predicted by BLAST, whereas points falling below the diagonal suggest mis-classification. The majority of sequences were at least 97% identical to the predicted species, which justifies species-level identification of rRNA sequences. We interpret the low maximum percent identity values obtained for some sequences (i.e.,<97% identity to any staphylococcal species, yet a top BLAST hit of S. aureus or S. epidermidis) as arising from base-calling or alignment errors inherent in analysis of pyrosequencing reads. Panel A. Nares sequences classified as S. aureus.Panel B. Nares sequences classified as S. epidermidis.
Figure 10. Distinct microbial populations in healthy…
Figure 10. Distinct microbial populations in healthy and hospitalized adults.
Pie charts depict average frequencies of dominant microorganisms in the anterior nares of healthy adults and inpatients, classified by S. aureus carriage status. Arrows outline possible pathways by which microbial populations develop in hospitalized patients. “Other” represents less abundant taxa, such as Proteobacteria and Firmicutes other than S. aureus and S. epidermidis.

References

    1. Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA. 2007;298:1763–1771.
    1. Noskin GA, Rubin RJ, Schentag JJ, Kluytmans J, Hedblom EC, et al. National trends in Staphylococcus aureus infection rates: impact on economic burden and mortality over a 6-year period (1998-2003). Clin Infect Dis. 2007;45:1132–1140.
    1. Nickerson EK, West TE, Day NP, Peacock SJ. Staphylococcus aureus disease and drug resistance in resource-limited countries in south and east Asia. Lancet Infect Dis. 2009;9:130–135.
    1. Kreisel K, Boyd K, Langenberg P, Roghmann MC. Risk factors for recurrence in patients with Staphylococcus aureus infections complicated by bacteremia. Diagnostic Microbiology & Infectious Disease. 2006;55(3):179–84.
    1. Velazquez-Guadarrama N, Martinez-Aguilar G, Galindo JA, Zuniga G, Arbo-Sosa A. Methicillin-resistant S. aureus colonization in Mexican children attending day care centres. Clin Invest Med. 2009;32:E57–63.
    1. Stacey AR, Endersby KE, Chan PC, Marples RR. An outbreak of methicillin resistant Staphylococcus aureus infection in a rugby football team. Br J Sports Med. 1998;32:153–154.
    1. Nguyen DM, Mascola L, Brancoft E. Recurring methicillin-resistant Staphylococcus aureus infections in a football team. Emerg Infect Dis. 2005;11:526–532.
    1. Kazakova SV, Hageman JC, Matava M, Srinivasan A, Phelan L, et al. A clone of methicillin-resistant Staphylococcus aureus among professional football players. N Engl J Med. 2005;352:468–475.
    1. Huijsdens XW, van Lier AM, van Kregten E, Verhoef L, van Santen-Verheuvel MG, et al. Methicillin-resistant Staphylococcus aureus in Dutch soccer team. Emerg Infect Dis. 2006;12:1584–1586.
    1. Pan ES, Diep BA, Carleton HA, Charlebois ED, Sensabaugh GF, et al. Increasing prevalence of methicillin-resistant Staphylococcus aureus infection in California jails. Clin Infect Dis. 2003;37:1384–1388.
    1. Gilbert M, MacDonald J, Gregson D, Siushansian J, Zhang K, et al. Outbreak in Alberta of community-acquired (USA300) methicillin-resistant Staphylococcus aureus in people with a history of drug use, homelessness or incarceration. CMAJ. 2006;175:149–154.
    1. Main CL, Jayaratne P, Haley A, Rutherford C, Smaill F, et al. Outbreaks of infection caused by community-acquired methicillin-resistant Staphylococcus aureus in a Canadian correctional facility. Can J Infect Dis Med Microbiol. 2005;16:343–348.
    1. LaMar JE, Carr RB, Zinderman C, McDonald K. Sentinel cases of community-acquired methicillin-resistant Staphylococcus aureus onboard a naval ship. Mil Med. 2003;168:135–138.
    1. Zinderman CE, Conner B, Malakooti MA, LaMar JE, Armstrong A, et al. Community-acquired methicillin-resistant Staphylococcus aureus among military recruits. Emerg Infect Dis. 2004;10:941–944.
    1. Beilman GJ, Sandifer G, Skarda D, Jensen B, McAllister S, et al. Emerging infections with community-associated methicillin-resistant Staphylococcus aureus in outpatients at an Army Community Hospital. Surg Infect (Larchmt) 2005;6:87–92.
    1. Ellis MW, Hospenthal DR, Dooley DP, Gray PJ, Murray CK. Natural history of community-acquired methicillin-resistant Staphylococcus aureus colonization and infection in soldiers. Clin Infect Dis. 2004;39:971–979.
    1. Wertheim HF, Vos MC, Ott A, van Belkum A, Voss A, et al. Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet. 2004;364:703–705.
    1. Perl TM, Cullen JJ, Wenzel RP, Zimmerman MB, Pfaller MA, et al. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med. 2002;346:1871–1877.
    1. Davis KA, Stewart JJ, Crouch HK, Florez CE, Hospenthal DR. Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection. Clin Infect Dis. 2004;39:776–782.
    1. Gorwitz RJ, Kruszon-Moran D, McAllister SK, McQuillan G, McDougal LK, et al. Changes in the Prevalence of Nasal Colonization with Staphylococcus aureus in the United States, 2001-2004. J Infect Dis. 2008;197:1226–1234.
    1. von Eiff C, Becker K, Machka K, Stammer H, Peters G. Nasal carriage as a source of Staphylococcus aureus bacteremia. N Engl J Med. 2001;344:11–16.
    1. Kuehnert MJ, Kruszon-Moran D, Hill HA, McQuillan G, McAllister SK, et al. Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001-2002. J Infect Dis. 2006;193:172–179.
    1. Wertheim HF, Melles DC, Vos MC, van Leeuwen W, van Belkum A, et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis. 2005;5:751–762.
    1. Kluytmans J, van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev. 1997;10:505–520.
    1. Quinn GA, Cole AM. Suppression of innate immunity by a nasal carriage strain of Staphylococcus aureus increases its colonization on nasal epithelium. Immunology. 2007;122:80–89.
    1. Peacock SJ, de SI, Lowy FD. What determines nasal carriage of Staphylococcus aureus? Trends in Microbiology. 2001;9(12):605–10.
    1. Regev-Yochay G, Dagan R, Raz M, Carmeli Y, Shainberg B, et al. Association between carriage of Streptococcus pneumoniae and Staphylococcus aureus in Children. JAMA. 2004;292(6):716–20.
    1. Bogaert D, van Belkum A, Sluijter M, Luijendijk A, de Groot R, et al. Colonisation by Streptococcus pneumoniae and Staphylococcus aureus in healthy children. Lancet. 2004;363(9424):1871–2.
    1. Lina G, Boutite F, Tristan A, Bes M, Etienne J, et al. Bacterial competition for human nasal cavity colonization: role of staphylococcal agr alleles. Applied & Environmental Microbiology. 2003;69(1):18–23.
    1. Francois P, Pittet D, Bento M, Pepey B, Vaudaux P, et al. Rapid detection of methicillin-resistant Staphylococcus aureus directly from sterile or nonsterile clinical samples by a new molecular assay. J Clin Microbiol. 2003;41:254–260.
    1. Lane DJ. 16S/23S rRNA sequencing. In: Stackebrandt E, Goodfellow M, editors. Nucleic acid techniques in bacterial systematics. New York: Wiley; 1991. pp. 115–175.
    1. Frank DN. BARCRAWL and BARTAB: Software tools for the design and implementation of barcoded primers for highly multiplexed DNA sequencing. BMC Bioinformatics. 2009;10:362.
    1. Yarza P, Richter M, Peplies J, Euzeby J, Amann R, et al. The All-Species Living Tree project: a 16S rRNA-based phylogenetic tree of all sequenced type strains. Syst Appl Microbiol. 2008;31:241–250.
    1. Wang Q, Garrity GM, Tiedje JM, Cole JR. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol. 2007;73:5261–5267.
    1. Cole JR, Wang Q, Cardenas E, Fish J, Chai B, et al. The Ribosomal Database Project: improved alignments and new tools for rRNA analysis. Nucleic Acids Res. 2009;37:D141–145.
    1. Pruesse E, Quast C, Knittel K, Fuchs B, Ludwig W, et al. SILVA: a comprehensive online resource for quality checked and aligned ribosomal RNA sequence data compatible with ARB. Nucleic Acids Res. 2007;35:7188–7196.
    1. Frank DN, Spiegelman GB, Davis W, Wagner E, Lyons E, et al. Culture-independent molecular analysis of microbial constituents of the healthy human outer ear. J Clin Microbiol. 2003;41:295–303.
    1. Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A. 2007;104:13780–13785.
    1. Frank DN, Wysocki A, Specht-Glick DD, Rooney A, Feldman RA, et al. Microbial diversity in chronic open wounds. Wound Repair Regen. 2009;17:163–172.
    1. Gao Z, Tseng CH, Pei Z, Blaser MJ. Molecular analysis of human forearm superficial skin bacterial biota. Proc Natl Acad Sci U S A. 2007;104:2927–2932.
    1. Grice EA, Kong HH, Conlan S, Deming CB, Davis J, et al. Topographical and temporal diversity of the human skin microbiome. Science. 2009;324:1190–1192.
    1. Kunin V, Engelbrektson A, Ochman H, Hugenholtz P. Wrinkles in the rare biosphere: pyrosequencing errors can lead to artificial inflation of diversity estimates. Environ Microbiol. 2010;12:118–123.
    1. Quince C, Lanzen A, Curtis TP, Davenport RJ, Hall N, et al. Accurate determination of microbial diversity from 454 pyrosequencing data. Nat Methods. 2009;6:639–641.
    1. Dethlefsen L, Huse S, Sogin ML, Relman DA. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol. 2008;6:e280.
    1. Tanner MA, Shoskes D, Shahed A, Pace NR. Prevalence of corynebacterial 16S rRNA sequences in patients with bacterial and “nonbacterial” prostatitis. J Clin Microbiol. 1999;37:1863–1870.
    1. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, et al. Diversity of the human intestinal microbial flora. Science. 2005;308:1635–1638.
    1. Bik EM, Eckburg PB, Gill SR, Nelson KE, Purdom EA, et al. Molecular analysis of the bacterial microbiota in the human stomach. Proc Natl Acad Sci U S A. 2006;103:732–737.
    1. Pei Z, Bini EJ, Yang L, Zhou M, Francois F, et al. Bacterial biota in the human distal esophagus. Proc Natl Acad Sci U S A. 2004;101:4250–4255.
    1. Harris JK, De Groote MA, Sagel SD, Zemanick ET, Kapsner R, et al. Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis. Proc Natl Acad Sci U S A. 2007;104:20529–20533.
    1. Fierer N, Hamady M, Lauber CL, Knight R. The influence of sex, handedness, and washing on the diversity of hand surface bacteria. Proc Natl Acad Sci U S A. 2008;105:17994–17999.
    1. Grice EA, Kong HH, Renaud G, Young AC, Bouffard GG, et al. A diversity profile of the human skin microbiota. Genome Res. 2008;18:1043–1050.
    1. Paulino LC, Tseng CH, Strober BE, Blaser MJ. Molecular analysis of fungal microbiota in samples from healthy human skin and psoriatic lesions. J Clin Microbiol. 2006;44:2933–2941.
    1. Aziz RK, Nizet V. Pathogen microevolution in high resolution. Sci Transl Med. 2010;2:16ps14.
    1. Harris SR, Feil EJ, Holden MT, Quail MA, Nickerson EK, et al. Evolution of MRSA during hospital transmission and intercontinental spread. Science. 2010;327:469–474.
    1. Frank JA, Reich CI, Sharma S, Weisbaum JS, Wilson BA, et al. Critical evaluation of two primers commonly used for amplification of bacterial 16S rRNA genes. Appl Environ Microbiol. 2008;74:2461–2470.
    1. Ewing B, Green P. Base-calling of automated sequencer traces using phred. II. Error probabilities. Genome Res. 1998;8:186–194.
    1. Ewing B, Hillier L, Wendl MC, Green P. Base-calling of automated sequencer traces using phred. I. Accuracy assessment. Genome Res. 1998;8:175–185.
    1. Frank DN. XplorSeq: a software environment for integrated management and phylogenetic analysis of metagenomic sequence data. BMC Bioinformatics. 2008;9:420.
    1. Ludwig W, Strunk O, Westram R, Richter L, Meier H, et al. ARB: a software environment for sequence data. Nucleic Acids Res. 2004;32:1363–1371.
    1. Good IJ. The population frequencies of species and the estimation of population parameters. Biometrika. 1953;40:237–264.
    1. Chao A, Lee S-M. Estimating the number of classes via sample coverage. J Amer Stat Assoc. 1992;87:210–217.
    1. Chao A. Nonparametric estimation of the number of classes in a population. Scand J Statist. 1984;11:265–270.
    1. R Development Core Team. Vienna, Austria: R Foundation for Statistical Computing; 2005. R: A Language and Environment for Statistical Computing.
    1. Oksanen J, Kindt R, Legendre P, O'Hara B, Simpson GL, et al. 2008. Vegan: Community Ecology Package. R package version 1.15-1. , .
    1. Kaufman L, Rousseeuw PJ. New York: Wiley; 2005. Finding Groups in Data: An Introduction to Cluster Analysis.
    1. Warnes GR. Gplots: Various R programming tools for plotting data. 2.6.0 ed. Available: .

Source: PubMed

3
Subscribe